CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,516
- in 1 filing
Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Cohen Neil Harris Director | Sale | −1,000 | $2.80 | $3K | 33,000 |
| 2026-08-27 | Cohen Neil Harris Director | Sale | −1,304 | $2.85 | $4K | 34,000 |
| 2023-01-03 | Mor George Adi Chief Scientific Officer | Sale | −7,700 | $5.03 | $39K | 317,075 |
| 2023-01-03 | Mor George Adi Chief Scientific Officer | Sale | −6,100 | $5.03 | $31K | 251,147 |
| 2023-01-03 | OrbiMed Israel GP Ltd. 10% owner | Sale | −266,376 | $3.34 | $890K | 2,311,798 |
| 2023-01-03 | OrbiMed Israel GP Ltd. 10% owner | Sale | −70,524 | $4.51 | $318K | 2,241,274 |
| 2022-11-16 | Cohen Neil Harris Director | Sale | −2,409 | $2.00 | $5K | 10,000 |
| 2022-11-16 | Mor George Adi Chief Scientific Officer | Sale | −324,775 | $2.08 | $677K | 324,775 |
| 2022-11-16 | Mor George Adi Chief Scientific Officer | Sale | −257,248 | $2.08 | $536K | 257,247 |
Page 1 of 1 · 9 trades